Upvote
Downvote
Chief Scientific Officer
Share Job
- Suggest Revision
- Experience working in gene therapy, gene editing/CRISPR, and/or RNAi required
- Kelonia Therapeutics is a preclinical, biotechnology company pioneering a new wave of genetic medicines using its
- In addition, Kelonia recently announced a research collaboration and license agreement with Astellas Pharma to develop novel immuno-oncology therapeutics.
- With this agreement, Kelonia will receive $40 million upfront for the first program, an additional $35 million should Astellas exercise its options for a second program, potential milestones and contingency payments approaching $800 million in total, and R&D funding for work performed in the collaboration.
- Kelonia seeks a strategic, highly accomplished scientist and enterprise leader, with a track record of translating science into medicines, to join the team as Chief Scientific Officer (CSO).
Active Job
Updated TodaySimilar Job
Relevance
Active